Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD300LD antisense RNA 1 (CD300LD-AS1) is a human non-coding RNA gene classified among long non-coding RNAs (lncRNAs) and antisense RNAs. It is transcribed from the DNA strand opposite to the CD300LD locus and commonly listed by aliases such as C17orf77 and FLJ31882. While antisense RNAs have established roles in gene expression regulation, epigenetic modulation, and mRNA stabilization, there is currently no evidence that CD300LD-AS1 encodes a receptor, transporter, enzyme, or therapeutic target, nor is there substantial published data about disease roles, interactions, or specific biological functions. Its status remains "uncharacterized".
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD300LD antisense RNA 1 (CD300LD-AS1).